Welcome to HemaCare Corporation – a leading global provider of biological blood products and services since 1978.
HemaCare Corporation is a blood services company serving healthcare providers and the scientific community for over 30 years. HemaCare and its subsidiary, Coral Blood Services, perform therapeutic apheresis services, provide human-derived biological products, and support the implementation of cellular therapy based trials with apheresis collections. Learn more
RESEARCH PRODUCTS
HemaCare provides a variety of human primary blood cells such as lymphocytes, monocytes, neutrophils, CD34+ and CD133+ stem cells, serum and much more!
- Normal donor subjects and patients
- Normal and mobilized peripheral blood
- Apheresis and whole blood derived

Human PBMC, Primary Cells, and Stem Cells
CELLULAR THERAPY
Quality of living cellular raw material is a major determinant of final product characteristics. Controlling and qualifying the cell collection step is essential to minimizing operational sources of variability, and greatly increases the likelihood of success in manufacturing. HemaCare’s specialty is apheresis collection, and, building on over 30 years of experience, has addressed this need for optimized cell collection with a program for controlling and qualifying its apheresis procedures and collection sites, bringing a higher degree of reproducibility to research projects or manufacturing efforts based on cGMP and cGTP principles.
THERAPEUTIC APHERESIS SAMPLE ORDER FORMS
DONATE BLOOD PLATELETS
ANNOUNCEMENTS
News
Tue, 07 Feb 2012 08:09:37 GMT |
Sun, 05 Feb 2012 16:55:30 GMT |
Wed, 01 Feb 2012 15:11:19 GMT |
Wed, 01 Feb 2012 13:09:24 GMT |
Tue, 31 Jan 2012 16:10:13 GMT |
Thu, 26 Jan 2012 16:01:20 GMT |
Tue, 24 Jan 2012 19:42:10 GMT |
Mon, 23 Jan 2012 20:14:12 GMT Small Stem Cell Study Claims Early Success in Treating Eye Disease |
Mon, 23 Jan 2012 14:10:11 GMT |
Wed, 18 Jan 2012 23:17:25 GMT |
Mon, 16 Jan 2012 16:47:28 GMT |
Fri, 13 Jan 2012 16:44:33 GMT |
Wed, 11 Jan 2012 14:20:43 GMT Stem Cell Therapy From Aastrom Biosciences and Cytori Therapeutics Looks to Gain Ground in 2012 |
Tue, 10 Jan 2012 08:11:45 GMT ASCO's Annual Progress Report Cites Significant Advances for 2011 |
Mon, 09 Jan 2012 14:40:15 GMT NW Bio Reaches 25 Clinical Trial Sites Open and Recruiting By the End of Q4, 2011 |
Events
11.23.2011 HemaCare will be presenting and exhibiting at Biopharmaceutical Development and Production Week: Biopharmaceutical Raw Materials throughout the Product Lifecycle Conference taking place from February 27 - 28, 2012 in San Diego, CA. Stop by booth #205 and say hello and learn more about our products and services. For more information on the meeting, please visit www.ibclifesciences.com
E-NEWSLETTER SIGN UP

Plasmapheresis
Plateletpheresis
Red Cell Exchange
Leukapheresis
Current Promotion
Hours and Locations
Make an Appointment
Donor Survey
Become a Research Donor